CURA ZIKA: AN INTERNATIONAL ALLIANCE
The University of Pittsburgh Graduate School of Public Health is proud to launch Cura Zika, an international alliance to perform much-needed research addressing the Zika epidemic by uniting Pitt biomedical scientists and their Brazilian collaborators.
Zika is a mosquito-borne and sexually transmitted virus which causes microcephaly in infants born to mothers infected with it. It is also associated with increased risk of Guillain-Barre syndrome and other neurological disorders in people who contract it. The virus is widespread in Southern and Central America and has a likelihood of gaining sustained transmission in the Southern U.S. this summer.
Cura Zika builds on Pitt Public Health’s long-standing collaboration with FIOCRUZ , the Brazilian Ministry of Health’s Fundação Oswaldo Cruz Foundation, the most prominent science and technology health institution in Latin America. Cura Zika – which means ‘Cure Zika’ in both Portuguese and Spanish – will provide quick access funding to scientists performing time-sensitive research on the virus. This support is designed to move early-stage innovative research ideas into larger studies in an accelerated manner.
An initial startup grant of $200,000 is being equally matched by funds from the Graduate School of Public Health and from the University of Pittsburgh schools of the health sciences. Already, an additional $800,000 in pledges has been received towards the alliance's efforts to fund research to stop the disease.